Diaceutics PLC (AIM:DXRX)
202.75
-1.25 (-0.61%)
Nov 6, 2026, 4:10 PM GMT
Diaceutics Revenue
In the year 2025, Diaceutics had annual revenue of 38.44M GBP with 19.53% growth. Diaceutics had revenue of 23.87M in the half year ending December 31, 2025, with 73.31% growth. That makes Diaceutics the 27,217th largest company in the world by revenue and 579th in the United Kingdom.
Revenue
38.44M
Revenue Growth
+19.53%
P/S Ratio
4.16
Revenue / Employee
201.60K
Employees
205
Market Cap
172.11M
Revenue by Geography
- North America 35.85M 93.3%
- Europe 1.79M 4.7%
- UK 766.00K 2.0%
- Asia and Rest of World 33.00K 0.1%
Fiscal year ended Dec 31, 2025 See the full Diaceutics breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 38.44M | 6.28M | 19.53% |
| Dec 31, 2024 | 32.16M | 8.46M | 35.69% |
| Dec 31, 2023 | 23.70M | 4.20M | 21.51% |
| Dec 31, 2022 | 19.50M | 5.56M | 39.88% |
| Dec 31, 2021 | 13.94M | 1.25M | 9.82% |
| Dec 31, 2020 | 12.70M | -746.00K | -5.55% |
| Dec 31, 2019 | 13.44M | 3.07M | 29.58% |
| Dec 31, 2018 | 10.37M | 3.00M | 40.74% |
| Dec 31, 2017 | 7.37M | 2.78M | 60.63% |
| Dec 31, 2016 | 4.59M | 3.19M | 228.33% |
| Dec 31, 2015 | 1.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 46.99B |
| GSK plc | 33.54B |
| Haleon | 11.15B |
| Smith & Nephew | 4.77B |
| Integrated Diagnostics Holdings | 140.66M |
| Optima Health | 120.64M |
| AOTI, Inc. | 52.74M |
| Tristel | 51.12M |
Diaceutics News
- 1 day ago - Diaceutics Transcript: Investor update - Transcripts
- 5 weeks ago - Diaceutics accelerates growth on precision medicine demand - The Armchair Trader
- 6 weeks ago - Diaceutics Quarterly report: H1 2026 - Filings
- 6 weeks ago - Diaceutics Slides: H1 2026 - Filings
- 3 months ago - Diaceutics Earnings release: H1 2026 - Filings
- 5 months ago - Diaceutics Earnings Call Transcript: H2 2025 - Transcripts
- 5 months ago - Diaceutics Annual report: H2 2025 - Filings
- 5 months ago - Diaceutics Annual report: H2 2025 - Filings